SURF
Income statement / Annual
Last year (2022), Surface Oncology, Inc.'s total revenue was $30.00 M,
an increase of 1,016.49% from the previous year.
In 2022, Surface Oncology, Inc.'s net income was -$65.30 M.
See Surface Oncology, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
| Operating Revenue |
$30.00 M
|
$2.69 M
|
$126.16 M
|
$15.36 M
|
$59.42 M
|
$12.83 M
|
$6.63 M
|
| Cost of Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Gross Profit |
$30.00 M |
$2.69 M |
$126.16 M |
$15.36 M |
$59.42 M |
$12.83 M |
$6.63 M |
| Gross Profit Ratio |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
| Research and Development
Expenses |
$67.00 M
|
$53.57 M
|
$41.02 M
|
$52.12 M
|
$52.49 M
|
$47.78 M
|
$20.49 M
|
| General & Administrative
Expenses |
$24.87 M
|
$25.13 M
|
$23.56 M
|
$20.61 M
|
$16.08 M
|
$11.03 M
|
$4.14 M
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$24.87 M
|
$25.13 M
|
$23.56 M
|
$20.61 M
|
$16.08 M
|
$11.03 M
|
$4.14 M
|
| Other Expenses |
$1.43 M |
$74,000.00 |
$0.00 |
$2.58 M |
$2.55 M |
$0.00 |
$0.00 |
| Operating Expenses |
$91.87 M |
$78.70 M |
$64.58 M |
$72.73 M |
$68.57 M |
$58.82 M |
$24.64 M |
| Cost And Expenses |
$91.87 M |
$78.70 M |
$64.58 M |
$72.73 M |
$68.57 M |
$58.82 M |
$24.64 M |
| Interest Income |
$0.00 |
$0.00 |
$0.00 |
$2.58 M |
$2.55 M |
$613,000.00 |
$551,000.00 |
| Interest Expense |
$1.72 M |
$2.47 M |
$2.25 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Depreciation &
Amortization |
$1.37 M
|
$1.57 M
|
$1.67 M
|
$1.79 M
|
$1.35 M
|
$964,000.00
|
$331,000.00
|
| EBITDA |
-$61.87 M
|
-$76.01 M
|
$61.59 M
|
-$57.37 M
|
-$9.15 M
|
-$45.03 M
|
-$17.67 M
|
| EBITDA Ratio |
-2.06 |
-28.29 |
0.49 |
-3.73 |
-0.15 |
-3.51 |
-2.66 |
| Operating Income Ratio
|
-2.06
|
-28.29
|
0.49
|
-3.73
|
-0.15
|
-3.59
|
-2.71
|
| Total Other
Income/Expenses Net |
-$1.72 M
|
-$2.47 M
|
-$2.25 M
|
$2.58 M
|
$2.55 M
|
$613,000.00
|
$551,000.00
|
| Income Before Tax |
-$63.59 M |
-$78.49 M |
$59.34 M |
-$54.79 M |
-$6.60 M |
-$45.38 M |
-$17.45 M |
| Income Before Tax Ratio
|
-2.12
|
-29.21
|
0.47
|
-3.57
|
-0.11
|
-3.54
|
-2.63
|
| Income Tax Expense |
$1.72 M |
$977,000.00 |
$579,000.00 |
-$1.79 M |
$2.55 M |
$0.00 |
$0.00 |
| Net Income |
-$65.30 M |
-$79.46 M |
$59.34 M |
-$53.00 M |
-$6.60 M |
-$45.38 M |
-$17.45 M |
| Net Income Ratio |
-2.18 |
-29.57 |
0.47 |
-3.45 |
-0.11 |
-3.54 |
-2.63 |
| EPS |
-1.17 |
-1.8 |
1.67 |
-1.9 |
-0.33 |
-2.35 |
-0.9 |
| EPS Diluted |
-1.17 |
-1.8 |
1.57 |
-1.9 |
-0.33 |
-2.35 |
-0.9 |
| Weighted Average Shares
Out |
$55.76 M
|
$44.24 M
|
$38.14 M
|
$27.85 M
|
$19.99 M
|
$19.34 M
|
$19.34 M
|
| Weighted Average Shares
Out Diluted |
$55.76 M
|
$44.24 M
|
$38.14 M
|
$27.85 M
|
$19.99 M
|
$19.34 M
|
$19.34 M
|
| Link |
|
|
|
|
|
|
|
